iECURE
Philadelphia
About iECURE
iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $115.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2022)
- Website: iecure.com
- Phone: (217) 817 -4800
Industries & Categories
Biotechnology, Genetics
Social Profiles
Canonical: https://fsome.com/organization/iecure-12343 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.